identified that post-transplant enhanced CXCL10/CXCR3 signaling in small-for-size liver grafts directly induced EPC mobilization, differentiation, and neovessel formation, which further promotes tumor growth (79). The gene discussed is CXCL10; the disease is neoplasm.